News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KUCHARCHUK ANDREW ALBERT
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2020 |
4
| KUCHARCHUK ANDREW ALBERT (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 241 convertible preferred
@ $0.0001, valued at
$0 |
|
| 05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2019 |
4/A
| KUCHARCHUK ANDREW ALBERT (CFO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
Granted 2,000,000 options to buy
@ $0.25, valued at
$500k
|
|
| 05/11/2018 |
4
| KUCHARCHUK ANDREW ALBERT (CFO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
|
|
| 04/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/04/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/04/2016 |
4
| KUCHARCHUK ANDREW ALBERT (CFO & President) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 5,000,000 shares
@ $0 |
|
| 02/04/2016 |
3
| KUCHARCHUK ANDREW ALBERT (CFO & President) has filed a Form 3 on OncBioMune Pharmaceuticals, Inc |
|
|